Krystal Biotech, Inc. KRYS Enterprise value

Enterprise value at other companies

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

Ultragenyx PharmaceuticalRARE

$1.83B-51.1%

BridgeBio PharmaBBIO

$16.77B+178%

Viridian Therapeutics, Inc.VRDN

$1.98B+79.5%

RegenxbioRGNX

$651.8M+51.8%

Zevra Therapeutics, Inc.ZVRA

$703.89M+36.7%

FAQ

What is Krystal Biotech, Inc.'s enterprise value?

Krystal Biotech, Inc. (KRYS) reported enterprise value of $7.06B in Q1 2026.

How has Krystal Biotech, Inc.'s enterprise value changed year-over-year?

Krystal Biotech, Inc.'s enterprise value increased by 44.2% year-over-year, from $4.89B to $7.06B.

What is the long-term trend for Krystal Biotech, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s enterprise value has grown at a 40.2% compound annual growth rate (CAGR), from $1.23B to $6.66B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.